OHI · NYSE · STOCK
Omega Healthcare Investors (OHI) Stock Analysis
$46.67
52W $39.26 – $52.39
64/100
$13.96B
16.1
0.57
⚠
Buy rating, but near-term risk/reward is unfavorable
The long-term recommendation is based on the composite investment score. The near-term risk/reward is based on nearby support and resistance levels. These can differ when a strong company trades close to resistance with support further below.
Is OHI Bullish or Bearish?
Bullish.
Innellis AI committee rates Omega Healthcare Investors (OHI) Buy with a composite score of 64/100
, based on 6 analysts with 67% agreement.
Last updated September 20, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +11.08 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -8.92 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The primary driver is eps growing 68.9% yoy. Most analysts agree, and no major concerns are blocking a stronger rating.
Bull & Bear Case
Bull Case
- ROE of 16.5% shows genuine earnings power backing the valuation — Value
- Dividend yield of 8.4% pays you to wait — Value
- EPS growing 68.9% YoY — Growth
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Current ratio of 0.91 is tight -- limited short-term liquidity cushion — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of September 20, 2026
Overall Committee Score
64/100
Agreement
67%
Analysts
6
Conviction
Moderate
Sector Rank
Top 2%
of 80 Real Estate peers
Value Analyst
bullish
63
/ 100 · Moderate confidence
Classic value case: cheap on multiples with earnings power to back it up
+ ROE of 16.5% shows genuine earnings power backing the valuation
Growth Analyst
bullish
79
/ 100 · High confidence
Strong, accelerating growth with consistent execution
+ EPS growing 68.9% YoY
Technical Analyst
neutral
58
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
Risk Analyst
neutral
52
/ 100 · Moderate confidence
Moderate risk -- no single red flag, but nothing that clearly de-risks the position either
− Current ratio of 0.91 is tight -- limited short-term liquidity cushion
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
bullish
66
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.25 across 8 articles, 14d)
Portfolio Manager
neutral
45
/ 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2518.64)
Investment Thesis Evolution
Committee score moved marginally from 63.9 to 63.9.
Comparing 2026-09-19 to 2026-09-20 (1 day apart).
Technical Analysis
RSI (14)
44.0
Neutral
MACD Histogram
0.098
Bullish Momentum
Trend Direction
Sideways
Weekly: Uptrend
Market Structure
Mixed
Support
$43.50
Resistance
$49.13
Bollinger %B
0.43
Inside Bands
Price vs Moving Averages
EMA 9
$46.98
Below
EMA 21
$47.02
Below
EMA 50
$47.32
Below
EMA 200
$46.04
Above
Fundamental Analysis
Valuation
93
Growth
90
Profitability
79
Financial Health
48
Cash Flow
70
Valuation
P/E Ratio
16.1×
P/B Ratio
2.59×
PEG Ratio
0.21
Dividend Yield
5.77%
52W High
$52.39
52W Low
$39.26
Quality & Growth
ROE
1138.9%
ROA
587.2%
Gross Margin
7196.1%
Operating Margin
6238.9%
Revenue Growth YoY
—
Debt / Equity
0.75
AI Fundamental Assessment
P/E ratio of 16.1 (inexpensive relative to a 15-40x range); Price-to-book of 2.6x; PEG ratio of 0.2 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 11.4%; Return on assets of 5.9%; Net margin of 66.4%; Gross margin of 72.0%; Current ratio of 0.91 (tight short-term liquidity); Debt-to-equity of 0.75; Free cash flow per share is positive (3.02); Most recent quarter beat estimates by 148.1%; 5 consecutive earnings beats; EPS growth accelerating (-9.1% -> +138.0% QoQ); Average YoY EPS growth of 158.7%; Analyst estimates flat over recent quarters
Get the Full OHI Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →